Evidence map›Paper›PMID 41338920›Full record

ArticleBMJ global health2025

Molecular investigation of

Mengyao Zhang, Zhiqiang Mi, Shuchao Wang, Mohamed Boie Jalloh, Peng Lyu, Xiaohong Song, Yuee Zhao, Jinlong Zhang, Yubiao Xie, Shipo Wu and 9 more

Abstract read
In one paragraph

Article in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Mengyao Zhang *Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.ORCID 0000-0002-3932-3160
Zhiqiang Mi *State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Shuchao Wang *Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, Jilin, China.
Mohamed Boie JallohNational Public Health Agency of Sierra Leone, Freetown, Sierra Leone.ORCID 0000-0001-9048-2952
Peng LyuLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.ORCID 0000-0002-5719-7997
Xiaohong SongLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.
Yuee ZhaoState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Jinlong ZhangLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.
Yubiao XieChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, Jilin, China.
Shipo WuLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.ORCID 0000-0001-8083-247X
Minghao ZhengLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.
Xiaoqiao LiLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.
Shangshu YangLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.
Busen WangLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.
Zhenghao ZhaoLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.ORCID 0000-0003-3117-0638
Stephen SevalieDefense Medical Services, Republic of Sierra Leone Armed Forces, Freetown, Sierra Leone.ORCID 0000-0003-2267-253X
Foday SahrNational Public Health Agency of Sierra Leone, Freetown, Sierra Leone cw0226@foxmail.com houlihua@sina.com fsahr65@gmail.com.
Lihua HouLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China cw0226@foxmail.com houlihua@sina.com fsahr65@gmail.com.ORCID 0000-0003-3644-2612
Wei ChenLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China cw0226@foxmail.com houlihua@sina.com fsahr65@gmail.com.ORCID 0000-0001-5805-2469

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMalaria remains a serious public health threat, especially in Africa. The challenge in detecting low-density

methodsIn 2022, during the COVID-19 pandemic, we conducted a nationally representative, age-stratified cross-sectional epidemiological survey in Sierra Leone during the rainy season to investigate the prevalence of

resultsAmong all 2112 samples, the

conclusionsThis study highlights the importance of molecular diagnosis in malaria-endemic areas for surveillance, diagnosis and treatment. The high prevalence of malaria infection among individuals aged ≥20 years, together with the high prevalence of asymptomatic, low-density infections, indicates a sustained potential transmission reservoir. Additionally, urban and rural malaria prevalence showed no statistically significant difference, a finding that underscores the need for greater attention to urban malaria.

Indexed as

MalariaPlasmodiumAdolescentAdultAgedChildChild, PreschoolCOVID-19Cross-Sectional StudiesFemaleHumansMaleMiddle AgedPrevalenceSierra LeoneYoung AdultCommunity-based surveyCross-sectional surveyEpidemiologyMalariaPCR

Identifiers

PMID41338920
PMCPMC12682196

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.